Education
About Us
Working with TipRanks
Follow Us
Soleno Therapeutics (SLNO)
:SLNO
Soleno Therapeutics (SLNO) Ownership Overview
10.05% Insiders
22.71% Mutual Funds
53.61% Other Institutional Investors
9.57% ETFs
4.07% Public Companies and
Individual Investors
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 85.89% of the company’s stock is owned by Institutional Investors, 10.05% is owned by Insiders, and 4.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $424792 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $2480110 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $700300 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $4883085 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $8436478 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $32194391 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $36062179 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,458,294 | Insider | 8.39% | 228,130,904 | |
| 2,204,030 | Institution | 4.15% | 112,780,215 | |
| 2,000,979 | Institution | 3.77% | 102,390,095 | |
| 1,561,082 | Institution | 2.94% | 79,880,566 | |
| 1,483,080 | Institution | 2.79% | 75,889,204 | |
| 1,123,087 | Institution | 2.11% | 57,468,362 | |
| 845,600 | Institution | 1.59% | 43,269,352 | |
| 675,131 | Institution | 1.27% | 34,546,453 | |
| 652,100 | Institution | 1.23% | 33,367,957 | |
| 614,833 | Institution | 1.16% | 31,461,005 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,000,979 | Institution | 3.77% | 102,390,095 | |
| 1,561,082 | Institution | 2.94% | 79,880,566 | |
| 1,123,087 | Institution | 2.11% | 57,468,362 | |
| 845,600 | Institution | 1.59% | 43,269,352 | |
| 652,100 | Institution | 1.23% | 33,367,957 | |
| 614,833 | Institution | 1.16% | 31,461,005 | |
| 586,455 | Institution | 1.10% | 30,008,902 | |
| 522,481 | Institution | 0.98% | 26,735,353 | |
| 441,100 | Institution | 0.83% | 22,571,087 | |
| 365,889 | Institution | 0.69% | 18,722,540 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,494,847 | Institution | 2.81% | 129,259,420 | |
| 1,000,512 | Institution | 1.88% | 51,196,199 | |
| 598,962 | Institution | 1.13% | 32,116,342 | |
| 362,452 | Institution | 0.68% | 31,341,224 | |
| 353,667 | Institution | 0.67% | 18,097,140 | |
| 191,400 | Institution | 0.36% | 16,550,358 | |
| 160,262 | Institution | 0.30% | 8,593,248 | |
| 115,645 | Institution | 0.22% | 5,917,555 | |
| 100,896 | Institution | 0.19% | 8,724,477 | |
| 56,258 | Institution | 0.11% | 3,016,554 |
FAQ
Who Owns Soleno Therapeutics (SLNO)?
According to the latest TipRanks data, approximately 53.61% of the company's stock is held by institutional investors, 10.05% is held by insiders, and 4.07% is held by retail investors.
What percentage of Soleno Therapeutics (SLNO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 53.61% of Soleno Therapeutics (SLNO) stock is held by institutional investors.
What percentage of Soleno Therapeutics (SLNO) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.07% of Soleno Therapeutics (SLNO) stock is held by retail investors.
Who owns the most shares of Soleno Therapeutics (SLNO)?
Vivo Opportunity, LLC owns the most shares of Soleno Therapeutics (SLNO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.